Hirschsprung disease (HD) or congenital aganglionic megacolon is an intestinal motor disorder with an incidence of 1:5000 live births, ranging from 1:14000 to 1:4000 live births (
1). It results in delayed meconium defecation, abdominal distension, lack of appetite, vomiting, and entrocolitis (
2). In several cases, the patients may be asymptomatic until adolescence and puberty years and 15% of cases remain undiagnosed until the age of 5 (
2,
3).
The gold standard of diagnosis is the pathological evaluation, revealing the absence of ganglion cells in the submucosal and myentric plexus, resulting in aperistaltism in the affected enteric regions and functional intestinal obstruction. Although the initial diagnosis is mainly based on clinical history and examination, followed only afterwards by pathological assessment (
4), radiographic contrast assessment may be useful in diagnosis (
5,
6). The risks associated with rectal biopsy, such as perforation, scar, stricture, bleeding and also anesthesia-related adverse effects, results in seeking several non-invasive techniques, such as imaging methods (
7,
8). A plain radiography may demonstrate a transition zone between a gas-filled colon and a non-dilated proximal colon, as a funnel-shaped region. Contrast enema (CE) with barium may be the first imaging procedure performed in the majority of centers, showing a transition zone, irregular colonic contractions, irregular mucosa suggesting enterocolitis, and an abnormal rectosigmoid index (RSI) (
9). These methods may have different sensitivity and specificity, based on age and length of involved region (
10-
16). Regarding the availability and feasibility of CE in most centers, and considering the role of prompt diagnosis and treatment of disease for the prevention of misdiagnoses and complications, the use of a non-invasive method, such as CE, would help the physicians to achieve a better management of the disease.